Challenges and Perspectives of the Hybridization of PET with Functional MRI or Ultrasound for Neuroimaging

Hybridization of positron emission tomography (PET) with other functional neuroimaging techniques such as functional magnetic resonance imaging (fMRI) or functional ultrasound (fUS) still raises technical and methodological challenges. Beyond the co-registration of anatomical images with functional data, development of hybrid imaging systems has paved the way for a large field of research based on the concept of bimodal functional neuroimaging such as PET/fMRI. In this framework, comparison of respective performances of brain PET and fUS suggests complementarity and great potential of hybrid PET/fUS for preclinical neuroimaging. Hybridization of functional neuroimaging techniques first offers opportunities to validate or improve measurement made by each modality. Future research may propose and validate hybrid parameters that quantitatively connect the brain molecular environment and the neuro-vascular coupling, which may improve our understanding of brain function in health and disease, with perspectives in neuroscience and neuropharmacology. In the coming years, cross-fertilization of neuroimaging communities and training of young researchers on multiple imaging modalities may foster the development of hybrid neuroimaging protocols that will take the full potential and the limitations of each modality into account.

[1]  Mohammad Mehdi Khalighi,et al.  Simultaneous phase‐contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease , 2020, Journal of magnetic resonance imaging : JMRI.

[2]  W. Heiss,et al.  The potential of PET/MR for brain imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[4]  Rupert Lanzenberger,et al.  Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity , 2017, Brain Structure and Function.

[5]  Y. Zhang,et al.  A Review of Magnetic Particle Imaging and Perspectives on Neuroimaging , 2019, American Journal of Neuroradiology.

[6]  Ian Law,et al.  Comparison of global cerebral blood flow measured by phase‐contrast mapping MRI with 15O‐H2O positron emission tomography , 2016, Journal of magnetic resonance imaging : JMRI.

[7]  Mickaël Tanter,et al.  Transcranial functional ultrasound imaging of the brain using microbubble-enhanced ultrasensitive Doppler , 2016, NeuroImage.

[8]  Mickael Tanter,et al.  Attenuation, scattering, and absorption of ultrasound in the skull bone. , 2011, Medical physics.

[9]  Charlie Demené,et al.  4D microvascular imaging based on ultrafast Doppler tomography , 2016, NeuroImage.

[10]  Georges El Fakhri,et al.  Motion compensation for brain PET imaging using wireless MR active markers in simultaneous PET–MR: Phantom and non-human primate studies , 2014, NeuroImage.

[11]  D. Vivien,et al.  Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System , 2018, Theranostics.

[12]  Thomas Beyer,et al.  The future of hybrid imaging—part 2: PET/CT , 2011, Insights into imaging.

[13]  M. Fink,et al.  Functional ultrasound imaging of the brain , 2011, Nature Methods.

[14]  ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies , 2020, NeuroImage.

[15]  E. Rabiner,et al.  Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  Praveen K Gulaka,et al.  Image-derived input function estimation on a TOF-enabled PET/MR for cerebral blood flow mapping , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  J. Gore,et al.  Neuromodulation of sensory networks in monkey brain by focused ultrasound with MRI guidance and detection , 2018, Scientific Reports.

[18]  R. Carson,et al.  PET physiological measurements using constant infusion. , 2000, Nuclear medicine and biology.

[19]  André Syrota,et al.  Processing of voices in deafness rehabilitation by auditory brainstem implant , 2009, NeuroImage.

[20]  Wim Vanduffel,et al.  Data collection and analysis strategies for phMRI , 2014, Neuropharmacology.

[21]  Victor W Pike,et al.  PET radiotracers: crossing the blood-brain barrier and surviving metabolism. , 2009, Trends in pharmacological sciences.

[22]  Ciprian Catana,et al.  Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  Ciprian Catana,et al.  Effect of MRI Acoustic Noise on Cerebral Fludeoxyglucose Uptake in Simultaneous MR-PET Imaging , 2013, Investigative radiology.

[24]  G. M. Godbersen,et al.  Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging , 2019, European Neuropsychopharmacology.

[25]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  G. Barker,et al.  Study design in fMRI: Basic principles , 2006, Brain and Cognition.

[27]  Keith St. Lawrence,et al.  A Noninvasive Method for Quantifying Cerebral Blood Flow by Hybrid PET/MRI , 2018, The Journal of Nuclear Medicine.

[28]  R. Friedland,et al.  PET quantification of specific binding of carbon-11-nicotine in human brain. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Bruce G. Jenkins,et al.  Pharmacologic magnetic resonance imaging (phMRI): Imaging drug action in the brain , 2012, NeuroImage.

[30]  I. Buvat,et al.  Physical blood‐brain barrier disruption induced by focused ultrasound does not overcome the transporter‐mediated efflux of erlotinib , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Mario Quarantelli,et al.  Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: A PET/MR hybrid scanner study , 2015, NeuroImage.

[32]  M. Honer,et al.  Radioligand development for molecular imaging of the central nervous system with positron emission tomography. , 2014, Drug discovery today.

[33]  P. Jezzard,et al.  Arterial spin labeling for the measurement of cerebral perfusion and angiography , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  J. Martinot,et al.  Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression Dopamine Transporter and Reward Anticipation in a Dimensional Perspective : A Multimodal Brain Imaging Study , 2017 .

[35]  Kewei Chen,et al.  Image-Derived Input Function for Brain PET Studies: Many Challenges and Few Opportunities , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  V. Calhoun,et al.  Integrity of Neurocognitive Networks in Dementing Disorders as Measured with Simultaneous PET/Functional MRI , 2020, The Journal of Nuclear Medicine.

[37]  F. Schick,et al.  Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales , 2013, Nature Medicine.

[38]  Christer Halldin,et al.  PET-MR and SPECT-MR multimodality probes: Development and challenges , 2018, Theranostics.

[39]  A. Joshi,et al.  Statistical evaluation of test-retest studies in PET brain imaging , 2018, EJNMMI Research.

[40]  K. Wong,et al.  Total Cerebral Blood Flow Estimated by Color Velocity Imaging Quantification Ultrasound: A Predictor for Recurrent Stroke? , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  Alan A. Wilson,et al.  GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study. , 2019, Journal of psychiatry & neuroscience : JPN.

[42]  B. Stieger,et al.  Imaging techniques to study drug transporter function in vivo. , 2018, Pharmacology & therapeutics.

[43]  Lucas Rischka,et al.  Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion , 2017, NeuroImage.

[44]  Andrew L. Alexander,et al.  Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates , 2018, The Journal of Neuroscience.

[45]  Alan A. Wilson,et al.  Interaction between TSPO—a neuroimmune marker—and redox status in clinical high risk for psychosis: a PET–MRS study , 2018, Neuropsychopharmacology.

[46]  N. Shah,et al.  Alternative headphones for patient noise protection and communication in PET-MR studies of the brain , 2018, EJNMMI Research.

[47]  G. M. Godbersen,et al.  Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR , 2019, Front. Mol. Neurosci..

[48]  Karl J. Friston,et al.  Local Activity Determines Functional Connectivity in the Resting Human Brain: A Simultaneous FDG-PET/fMRI Study , 2014, The Journal of Neuroscience.

[49]  Elodie Tiran,et al.  EEG and functional ultrasound imaging in mobile rats , 2015, Nature Methods.

[50]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  Koen Van Laere,et al.  EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[52]  M. Tanter,et al.  Performance evaluation of the PET component of a hybrid PET/CT-ultrafast ultrasound imaging instrument , 2018, Physics in medicine and biology.

[53]  Peter A. Bandettini,et al.  Twenty years of functional MRI: The science and the stories , 2012, NeuroImage.

[54]  Xiaohua Zhu,et al.  MRI-Driven PET Image Optimization for Neurological Applications , 2019, Front. Neurosci..

[55]  M. Versluis,et al.  Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[56]  A. Kashuba,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System , 2018, Clinical Pharmacokinetics.

[57]  Egill Rostrup,et al.  Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences , 2004, NeuroImage.

[58]  Andreas Meisel,et al.  Sugar for the brain: the role of glucose in physiological and pathological brain function , 2013, Trends in Neurosciences.

[59]  Thomas Deffieux,et al.  Functional ultrasound neuroimaging: a review of the preclinical and clinical state of the art , 2018, Current Opinion in Neurobiology.

[60]  O B Paulson,et al.  Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. , 1984, The Journal of clinical investigation.

[61]  M. Imaizumi,et al.  Clinical significance of cerebrovascular reserve in acetazolamide challenge —comparison with acetazolamide challenge H2O-PET and Gas-PET— , 2004, Annals of nuclear medicine.

[62]  M. Tanter,et al.  Functional ultrasound imaging of brain activity in human newborns , 2017, Science Translational Medicine.

[63]  Nicole R. Zürcher,et al.  Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis , 2018, NeuroImage: Clinical.

[64]  J. Rauschecker,et al.  Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease—A simultaneous resting‐state FDG‐PET/fMRI study , 2019, Human brain mapping.

[65]  V. Pike Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging. , 2016, Current medicinal chemistry.

[66]  Marco Salvatore,et al.  Hybrid PET/MR Imaging and Brain Connectivity , 2016, Front. Neurosci..

[67]  Hsiao-Ying Wey,et al.  Advances in simultaneous PET/MR for imaging neuroreceptor function , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[68]  H. Daldrup-Link,et al.  Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans , 2019, Molecular Imaging and Biology.

[69]  Ninon Burgos,et al.  Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[70]  M. Tanter,et al.  Functional imaging evidence for task-induced deactivation and disconnection of a major default mode network hub in the mouse brain , 2020, Proceedings of the National Academy of Sciences.

[71]  David Atkinson,et al.  Incorporation of MRI-AIF information for improved kinetic modelling of dynamic PET data , 2015, IEEE Transactions on Nuclear Science.

[72]  N Tokgoz,et al.  Blood-flow volume quantification in internal carotid and vertebral arteries: comparison of 3 different ultrasound techniques with phase-contrast MR imaging. , 2006, AJNR. American journal of neuroradiology.

[73]  G Montaldo,et al.  MR-guided adaptive focusing of ultrasound , 2010, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[74]  Karl J. Friston,et al.  Metabolic connectivity mapping reveals effective connectivity in the resting human brain , 2015, Proceedings of the National Academy of Sciences.

[75]  Britta Wandschneider,et al.  Pharmaco fMRI: Determining the functional anatomy of the effects of medication , 2016, NeuroImage: Clinical.

[76]  B. K. Swann,et al.  PET/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet. , 2007, Radiology.

[77]  Bruce R. Rosen,et al.  Dynamic functional imaging of brain glucose utilization using fPET-FDG , 2014, NeuroImage.

[78]  S. Mériaux,et al.  About the Marty model of blood-brain barrier closure after its disruption using focused ultrasound , 2019, Physics in medicine and biology.

[79]  M. Raichle,et al.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[80]  Koen Van Laere,et al.  Optimized In Vivo Detection of Dopamine Release Using 18F-Fallypride PET , 2012, The Journal of Nuclear Medicine.

[81]  T Knopp,et al.  Human-sized magnetic particle imaging for brain applications , 2018, Nature Communications.

[82]  J. E. Mackewn,et al.  Practical issues and limitations of brain attenuation correction on a simultaneous PET-MR scanner , 2020, EJNMMI Physics.

[83]  Mickael Tanter,et al.  Simultaneous positron emission tomography and ultrafast ultrasound for hybrid molecular, anatomical and functional imaging , 2018, Nature Biomedical Engineering.

[84]  Ciprian Catana,et al.  Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI , 2016, Neuropsychopharmacology.

[85]  Ruth O'Gorman Tuura,et al.  Imaging glutamate redistribution after acute N-acetylcysteine administration: A simultaneous PET/MR study , 2019, NeuroImage.

[86]  Francesco Sforazzini,et al.  Simultaneous task-based BOLD-fMRI and [18-F] FDG functional PET for measurement of neuronal metabolism in the human visual cortex , 2018, NeuroImage.

[87]  O. Langer,et al.  Imaging P‐Glycoprotein Function at the Blood–Brain Barrier as a Determinant of the Variability in Response to Central Nervous System Drugs , 2019, Clinical pharmacology and therapeutics.

[88]  Mario Quarantelli,et al.  Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity , 2018, NeuroImage.

[89]  S. Hesse,et al.  News and views on in-vivo imaging of neurotransmission using PET and MRI. , 2017, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[90]  C. J. Gauthier,et al.  BOLD signal physiology: Models and applications , 2019, NeuroImage.

[91]  M. Aiello,et al.  Multimodal Neuroimaging Approach to Variability of Functional Connectivity in Disorders of Consciousness: A PET/MRI Pilot Study , 2018, Front. Neurol..

[92]  Junming Shao,et al.  Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study , 2016, The Journal of Nuclear Medicine.

[93]  Mikko Sams,et al.  Dissociable Roles of Cerebral &mgr;-Opioid and Type 2 Dopamine Receptors in Vicarious Pain: A Combined PET–fMRI Study , 2017, Cerebral cortex.

[94]  Liesbeth Reneman,et al.  ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies , 2019, NeuroImage.

[95]  Elodie Tiran,et al.  Transcranial Functional Ultrasound Imaging in Freely Moving Awake Mice and Anesthetized Young Rats without Contrast Agent , 2017, Ultrasound in medicine & biology.

[96]  C. Claussen,et al.  Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1 , 2022 .

[97]  Paul K Marsden,et al.  Simultaneous PET and NMR. , 2002, The British journal of radiology.

[98]  Hesamoddin Jahanian,et al.  Comparison of cerebral blood flow measurement with [15O]-water positron emission tomography and arterial spin labeling magnetic resonance imaging: A systematic review , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[99]  Nicolas Costes,et al.  In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging , 2018, Neuropsychopharmacology.

[100]  Mickael Tanter,et al.  Functional ultrasound imaging of intrinsic connectivity in the living rat brain with high spatiotemporal resolution , 2014, Nature Communications.

[101]  B. Bodini,et al.  Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[102]  Jean-François Aubry,et al.  Magnetic resonance-guided motorized transcranial ultrasound system for blood-brain barrier permeabilization along arbitrary trajectories in rodents , 2015, Journal of therapeutic ultrasound.

[103]  Richard G. Wise,et al.  Graded Hypercapnia-Calibrated BOLD: Beyond the Iso-metabolic Hypercapnic Assumption , 2017, Front. Neurosci..

[104]  Evan D Morris,et al.  Positron Emission Tomography Displacement Sensitivity: Predicting Binding Potential Change for Positron Emission Tomography Tracers Based on Their Kinetic Characteristics , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[105]  Ciprian Catana,et al.  Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI , 2013, Proceedings of the National Academy of Sciences.

[106]  Anthonin Reilhac,et al.  Bayesian Estimation of the ntPET Model in Single-Scan Competition PET Studies , 2020, Frontiers in Physiology.

[107]  J. Frank,et al.  In vivo imaging of sterile microglial activation in rat brain after disrupting the blood-brain barrier with pulsed focused ultrasound: [18F]DPA-714 PET study , 2019, Journal of Neuroinflammation.

[108]  Roger Fulton,et al.  The design and implementation of a motion correction scheme for neurological PET. , 2003, Physics in medicine and biology.

[109]  E. Rabiner,et al.  The application of positron emission tomography (PET) imaging in CNS drug development , 2018, Brain Imaging and Behavior.

[110]  Peter Harvey,et al.  Probing the brain with molecular fMRI , 2018, Current Opinion in Neurobiology.

[111]  L. Zimmer,et al.  Functional ultrasound imaging to study brain dynamics: Application of pharmaco-fUS to atomoxetine , 2020, Neuropharmacology.

[112]  J. Maldjian,et al.  Brain perfusion imaging: How does it work and what should I use? , 2012, Journal of magnetic resonance imaging : JMRI.

[113]  Zhaolin Chen,et al.  Analysis of continuous infusion functional PET (fPET) in the human brain , 2020, NeuroImage.

[114]  Paul M. Matthews,et al.  Positron emission tomography molecular imaging for drug development. , 2012, British journal of clinical pharmacology.

[115]  Francesco Sforazzini,et al.  From simultaneous to synergistic MR‐PET brain imaging: A review of hybrid MR‐PET imaging methodologies , 2018, Human brain mapping.

[116]  Stéphane Lehéricy,et al.  MRI monitoring of temperature and displacement for transcranial focus ultrasound applications , 2020, NeuroImage.

[117]  Egill Rostrup,et al.  Comparison of simultaneous arterial spin labeling MRI and 15O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[118]  F. O’Sullivan,et al.  Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease , 2014, The Journal of Nuclear Medicine.

[119]  M. Tanter,et al.  Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment , 2020, Theranostics.

[120]  Mark D Pagel,et al.  Advances in Magnetic Resonance Imaging Contrast Agents for Biomarker Detection. , 2016, Annual review of analytical chemistry.

[121]  Sushmita Purkayastha,et al.  Transcranial Doppler Ultrasound: Technique and Application , 2012, Seminars in Neurology.

[122]  Mickael Tanter,et al.  Intraoperative Functional Ultrasound Imaging of Human Brain Activity , 2017, Scientific Reports.